DIACOMIT 500 mg Powder for Oral Suspension
RxNorm 2055014
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2055014 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: DIACOMIT 500 mg Powder for Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
DIACOMIT 500 mg Powder for Oral Suspension
(Atom ID: 10330351)
SYPrescribable
Synonym (SY):
Diacomit 500 mg Powder for Oral Suspension
(Atom ID: 10330352)
SBDPrescribable
Semantic Branded Drug (SBD):
Stiripentol 500 mg Powder for Oral Suspension [Diacomit]
(Atom ID: 10330350)
Patient Education
Stiripentol
Stiripentol is used along with clobazam (OnfiĀ®) to control seizures in adults and children 2 years of age and older who have Dravet syndrome (a disorder that begins in early childhood and causes seizures and later may lead to developmental delays and changes in eating, balance, and walking). Stiripentol is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement activity in the brain.
[Learn More]
* Please review the disclaimer below.